Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
211.53
-13.47 (-5.99%)
Oct 12, 2026, 3:10 PM EDT - Market open
Moderna Market Cap
Moderna has a market cap or net worth of $84.45 billion as of October 12, 2026. It is the 270th most valuable company in the world and the 146th biggest in the United States. Its market cap has increased by 705.88% in one year.
Market Cap
84.45B
Enterprise Value
78.83B
1-Year Change
705.88%
Global Rank
Country Rank
#146 United States
Category
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $84.45B, an increase of 1,280.26%. That is a compound annual growth rate of 39.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 84.45B | 632.90% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 129.29B |
| Regeneron Pharmaceuticals | 74.55B |
| argenx SE | 51.01B |
| Revolution Medicines | 40.67B |
| BeOne Medicines AG | 40.30B |
| Royalty Pharma | 32.73B |
| Alnylam Pharmaceuticals | 31.13B |
| Roivant Sciences | 25.60B |